Posted by Michael Wonder on 20 Mar 2023
Resignations at Canada’s drug pricing panel raise independence questions
14 March 2023 - A member of Canada’s drug pricing regulator has resigned, stating the federal government has undermined the independence and credibility of the organisation.
Dalhousie University health law expert Matthew Herder’s resignation from the Patented Medicine Prices Review Board comes after reports of federal interference in the arms length regulator’s work and the resignation of its acting chair late last year.
